AzTrials
AzTrials

Oral Bacterial InfectionEASIERNCT06193512

Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study

A study testing SwishKit + Oral care treatment as usual and Oral care treatment as usual in people with Oral Bacterial Infection and Mechanical Ventilation Complication, run by The Cleveland Clinic at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

We propose a randomized pilot/feasibility study comparing oral care treatment as usual (TAU) with Swiftsure SwishKit plus oral care TAU on the presence and magnitude of bacterial load in the oropharyngeal space in orotracheally intubated patients. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
SwishKit + Oral care treatment as usual and Oral care treatment as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteUnited States
Study dates
8 Mar 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults, 18 years or older
  • Individual or legally authorized representative consent
  • Intubated with an oral endotracheal tube and expected to remain intubated for at least 2 days.

Who cannot join

  • Maxillofacial trauma (current maxillofacial trauma precluding standard oral care techniques)
  • Conditions precluding lateral Trendelenburg positioning (e.g., increased intracranial pressure, spinal instability, hemodynamic instability)
  • Oropharyngeal injury or infection
  • Orofacial edema precluding access for oral care
  • Known or anticipated difficult intubation
  • Endotracheal cuff air leak that clinicians believe precludes mouth lavage
  • Already intubated for more than 24 continuous hours within a week before enrollment.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195

Other trials in United States

About this study

Official title: Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study (EASIER PILOT)

We propose a randomized pilot/feasibility study comparing oral care treatment as usual (TAU) with Swiftsure SwishKit plus oral care TAU on the presence and magnitude of bacterial load in the oropharyngeal space in orotracheally intubated patients. The trial will be conducted with IRB approval and written consent from patient or its legal representative.

Read the detailed description

Qualifying patients will be assigned on a 1:2 (control : treatment intervention) basis using computer-generated codes and random block sizes without stratification to the following groups:

  • Oral care TAU
  • Swiftsure SwishKit oral flush plus oral care Treatment as Usual (SK+Oral care TAU)

In the Oral care TAU group, oral care will be delivered per standard operating procedure of the ICU, which may include the instillation of chemical agents for the purpose of reducing bacterial load, will be administered at 4-hour intervals, and tooth brushing performed twice daily (morning and evening). In the SK+Oral care TAU group, instillation of chemical antimicrobial agents care and tooth brushing will be performed as in Oral Care TAU, but SwishKit care will be conducted after other oral care interventions, and prior to instillation of the chemical antimicrobial agent. In both groups, treatment will be conducted for up to 5 days, or until extubation.

Detailed interventions:

Oral care TAU (Treatment as Usual) Standard oral care procedures are designed to help remove microorganisms from mouth surfaces and represent a comprehensive suite of interventions. Oral care provision is codified in a written oral care protocol at the Critical Care unit. The Association of Critical Care Nurses calls for oral care every 2-4 hours. This protocol calls for oral care provision at 4-hour intervals. Oral hygiene will consist of assessment of any plaque buildup on teeth or presence of infection. Brushing and cleaning of the mouth surfaces, followed by administration of a moisturizer to the oral mucosa and lips is required. Oral care includes an assessment of the patient on admission to identify oral health status and self-care deficiencies for further action. Dental plaque removal by brushing the teeth with a soft toothbrush at least twice a day is intended to help remove dental plaque. A toothpaste to assist in breakdown of mucous and biofilm can be administered during brushing. Specific to TAU, nursing will help maintain saliva production to minimize mucositis. The head of the bed will be elevated to at least 30° and positioned to allow secretions to pool in the buccal pocket (especially during tooth brushing and feeding), and the provision of sub-glottic suctioning as needed dependent on mucous production.

SwishKit + Oral care TAU The SwishKit device will be used in accordance with the Operators Manual. The SwishKit device will be inserted into the mouth of the patient by a nurse, and the patient will be properly positioned before use of the device.

A total of 60 mL of 0.9% NaCl will be instilled using three x 20 mL aliquots delivered by syringe (syringe inlet), and immediately evacuated by suction. Upon completion, the SwishKit will be removed and disposed of. The nurse will assure that there is no residual saline or other fluid in the mouth or upper airway, and original position for care resumed.

Being tested
SwishKit + Oral care treatment as usual, Oral care treatment as usual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SwishKit + Oral care treatment as usualDevice

    SwishKit + Oral care Treatment as usual (TAU) group, instillation of chemical antimicrobial agents care and tooth brushing will be performed as in Oral Care TAU, but SwishKit care will be conducted after other oral care interventions, and prior to instillation of the chemical antimicrobial agent.

  • Oral care treatment as usualProcedure or surgery

    Oral care will be delivered per standard operating procedure of the ICU, which may include the instillation of chemical agents for the purpose of reducing bacterial load, will be administered at 4-hour intervals, and tooth brushing performed twice daily (morning and evening).

Study groups in NCT06193512
Study groupRoleWhat they receive
SwishKit + Oral care treatment as usualExperimentalSwishKit + Oral care Treatment as usual (TAU)
Receives: Device: SwishKit + Oral care treatment as usual
Oral care treatment as usualActive comparatorOral care Treatment as usual (TAU)
Receives: Procedure: Oral care treatment as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bacterial load in the oropharyngeal space

    Incidence of the presence of bacterial load in the oropharyngeal space from culture and qPCR of the five target pathogens: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.

    Measured: Within 5 days after enrolment.

Secondary outcomes (3)
  1. Colony-Forming Units/milliliter (ml) (CFU/ml)

    Mean colony-forming units/milliliter (ml) (CFU/ml).

    Measured: Within 5 days after enrolment.

  2. 16S rRNA sequencing of bacteria

    16S rRNA sequencing for bacterial identifications and bioinformatics analysis.

    Measured: Within 5 days after enrolment.

  3. Colony-Forming Units/milliliter (ml) (CFU/ml) and 16S rRNA

    Changes in colony-forming units/milliliter (ml) (CFU/ml) and 16S rRNA sequencing between before and after treatment at morning 1 and morning 2.

    Measured: Within 2 days after enrolment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2024
  2. Study start8 Mar 2024
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized controlled study
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
21 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06193512
Sponsor's protocol ID
23-884
Acronym
EASIER
Status last verified
Mar 2026
First submitted
29 Nov 2023
Last updated
30 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SwishKit + Oral care treatment as usual and Oral care treatment as usual in people with Oral Bacterial Infection and Mechanical Ventilation Complication, run by The Cleveland Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bacterial load in the oropharyngeal space (time frame: Within 5 days after enrolment.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in